{"nct_id":"NCT00002353","title":"A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects","status":"COMPLETED","status_verified_date":"1997-07","start_date":null,"start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["UNH"]}